Adverum Biotechnologies, Inc. (ADVM)

Dec 9, 2025 - ADVM was delisted (reason: acquired by LLY)

4.360

+0.100 (2.35%)

Inactive · Last trade price on Dec 8, 2025

Adverum Biotechnologies Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Income	-184.79	-130.93	-122.12	-154.54	-145.54	-117.51
Depreciation & Amortization	2.49	3.65	5.64	6.53	4.65	4.16
Loss (Gain) From Sale of Assets	0.01	0	0.05	0.12	-	-
Asset Writedown & Restructuring Costs	-	-	-	2.12	1.06	-
Loss (Gain) From Sale of Investments	-1.16	-1.91	-1.94	-0.88	2.77	0.52
Stock-Based Compensation	10.83	14.35	17.57	20.08	25.19	20.39
Other Operating Activities	12.79	21.46	18.39	2.62	-0.03	0.42
Change in Accounts Payable	10.39	-0.26	-0.37	0.85	-1.61	1.59
Change in Other Net Operating Assets	11.54	1.17	-8.14	15	5.67	11.14
Operating Cash Flow	-137.9	-92.46	-90.9	-108.09	-107.83	-79.29
Operating Cash Flow Growth	-	-	-	-	-	-

Investing Activities

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Capital Expenditures	-0.54	-0.39	-0.81	-11.82	-15.12	-11.84
Investment in Securities	61.4	-41.5	97.68	153.54	93.83	-268.32
Investing Cash Flow	60.85	-41.89	96.88	141.72	78.71	-280.17

Financing Activities

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Long-Term Debt Repaid	-	-	-	-	-0.24	-0.06
Net Debt Issued (Repaid)	-	-	-	-	-0.24	-0.06
Issuance of Common Stock	10.26	120	0.49	0.61	2.64	358.09
Repurchase of Common Stock	-	-	-	-	-	-2.04
Other Financing Activities	-	-	-0.42	-	-	-
Financing Cash Flow	10.26	120	0.07	0.61	2.4	355.99

Net Cash Flow

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Cash Flow	-66.79	-14.35	6.04	34.24	-26.73	-3.47

Free Cash Flow

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Free Cash Flow	-138.45	-92.85	-91.71	-119.91	-122.95	-91.14
Free Cash Flow Growth	-	-	-	-	-	-
Free Cash Flow Margin	-	-9285.00%	-2547.50%	-	-1639.39%	-
Free Cash Flow Per Share	-6.41	-4.69	-9.10	-12.08	-12.54	-10.70
Levered Free Cash Flow	-78.24	-66	-63.92	-72.63	-80.16	-54.76
Unlevered Free Cash Flow	-78.24	-66	-63.92	-72.63	-80.16	-54.76

Additional Metrics

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Change in Working Capital	21.93	0.91	-8.51	15.85	4.06	12.73

SEC Filings: 10-K · 10-Q